Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer, it remains a huge challenge to understand the cellular and molecular mechanisms of the aggressive behavior of EOC cells. Here we investigated the role of an immunomodulatory cytokine IL-33 and its receptor ST2 in mediating the growth and metastasis of EOC. Our data show that both IL-33 and ST2 were highly up-regulated in EOC tumors compared with normal ovary and ovarian benign tumors, and the expression levels were further increased in tumor tissues at the metastatic site. The expression levels of IL-33 and ST2 were positively correlated with the Ki-67 expression, and negatively correlated with the patient survival time. Using EOC cell lines, we observed that cells kno...
Soft tissue sarcoma (STS) is a rare solid malignant cancer, and there are few effective treatment op...
Interleukin-33 (IL-33)/IL-33 receptor (IL-33R, ST2) signaling pathway promotes mammary cancer growth...
Abstract Background Emerging evidence has suggested that interleukin (IL)-33 and its primary functio...
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer, it remains a huge challenge...
Interleukin-33 (IL-33), a member of the IL-1 cytokine family, plays a critical role in maintaining t...
Cancer is initiated by mutations in critical regulatory genes; however, its progression to malignanc...
The role of IL-33/ST2 pathway in antitumor immunity is unclear. Using 4T1 breast cancer model we dem...
Background: Despite the importance of inflammation in cancer, the role of the cytokine IL-33, and it...
Interleukin-33 (IL-33) is an epithelial-derived cytokine that can be released upon tissue damage, st...
Abstract Background Interleukin-33 (IL-33) participates in various types of diseases including cance...
Interleukin-33 (IL-33) is a member of the IL-1 family of cytokines that is constitutively expressed ...
BackgroundProinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in infla...
The human Interleukin-33 (IL-33), a member of the IL-1 family, is the cytokine as a cell endogenous ...
Interleukin-33 (IL-33), considered as an alarmin released upon tissue stress or damage, is a member ...
-Most sporadic colorectal cancers (CRCs) develop from preformed adenomas. Cytokines are involved in ...
Soft tissue sarcoma (STS) is a rare solid malignant cancer, and there are few effective treatment op...
Interleukin-33 (IL-33)/IL-33 receptor (IL-33R, ST2) signaling pathway promotes mammary cancer growth...
Abstract Background Emerging evidence has suggested that interleukin (IL)-33 and its primary functio...
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer, it remains a huge challenge...
Interleukin-33 (IL-33), a member of the IL-1 cytokine family, plays a critical role in maintaining t...
Cancer is initiated by mutations in critical regulatory genes; however, its progression to malignanc...
The role of IL-33/ST2 pathway in antitumor immunity is unclear. Using 4T1 breast cancer model we dem...
Background: Despite the importance of inflammation in cancer, the role of the cytokine IL-33, and it...
Interleukin-33 (IL-33) is an epithelial-derived cytokine that can be released upon tissue damage, st...
Abstract Background Interleukin-33 (IL-33) participates in various types of diseases including cance...
Interleukin-33 (IL-33) is a member of the IL-1 family of cytokines that is constitutively expressed ...
BackgroundProinflammatory interleukin-33 (IL-33) binds to its receptor ST2L and is involved in infla...
The human Interleukin-33 (IL-33), a member of the IL-1 family, is the cytokine as a cell endogenous ...
Interleukin-33 (IL-33), considered as an alarmin released upon tissue stress or damage, is a member ...
-Most sporadic colorectal cancers (CRCs) develop from preformed adenomas. Cytokines are involved in ...
Soft tissue sarcoma (STS) is a rare solid malignant cancer, and there are few effective treatment op...
Interleukin-33 (IL-33)/IL-33 receptor (IL-33R, ST2) signaling pathway promotes mammary cancer growth...
Abstract Background Emerging evidence has suggested that interleukin (IL)-33 and its primary functio...